Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PERK is a type I transmembrane serine/threonine-protein kinase located in the endoplasmic reticulum (ER) membrane. It is one of three principal ER stress sensors that mediate the unfolded protein response (UPR), alongside IRE1 and ATF6. PERK reduces global protein synthesis during ER stress to alleviate folding load by phosphorylating eIF2α at Ser51, inhibiting formation of active eIF2-GTP-tRNAi^Met complex. This attenuates general mRNA translation but allows selective translation of specific mRNAs such as ATF4 that help restore homeostasis or trigger apoptosis if stress persists.
Kinase Inhibitor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PKR-like Endoplasmic Reticulum Kinase (PERK).